Medicines and advertising regulators examine Ozempic maker’s Irish ads
We need your help now Support from readers like you keeps The Journal open. You are visiting us…
A Genetic Risk Score for GLP-1 Agonist-Related Nausea
Credit: solar22/Getty Images A team led by researchers at Mayo Clinic have used proprietary algorithms and genetic data…
The Benefits of High-Protein Diets for Weight Loss
This transcript has been edited for clarity. Hi. I’m Dr Lucas. I’m board certified in internal medicine and…
Rise in local areas in England with at least a third of adults obese – The Irish News
A growing number of local areas in England are estimated to have at least a third of adults…
Patients struggle as compounded GLP-1 access rapidly shrinks
The explosion of compounded GLP-1 offerings over the past two years is coming to an end, and many…
Diabetes drug demand soars – The Royal Gazette
New tools in healthcare: diabetes medications Mounjaro, left, and Ozempic, both of which are kept refrigerated at the…
GLP-1 RAs in Eating Disorders: Promising or Perilous?
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) continue to skyrocket in popularity as both approved and off-label treatments…
UK public backs food tax, if it makes healthy food more affordable
A major UK survey shows strong public support for food taxes, especially when designed to lower the cost…
Scientists make huge discovery about ‘dessert stomach’ condition | UK | News
Just in time for Easter Sunday, scientists have found natural bodily reactions can compel us to eat something…
Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery
Ethics statement This study complies with all relevant ethical regulations and was conducted in accordance with the research…